“Studies were small and of poor methodological quality, with selective recruitment, high rates of unevaluable images, and differential verification.”
Excellent re-visit of the actual science and validity of direct-to-consumer app-based medicine for the diagnosis of skin cancer. bmj.m127.full.pdf (422 KB)